The Clinical Study of Improving the Thirst and Hypotension of Hemodialysis Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02583802|
Recruitment Status : Unknown
Verified October 2015 by Cao po, Beijing University of Chinese Medicine.
Recruitment status was: Recruiting
First Posted : October 22, 2015
Last Update Posted : October 22, 2015
|Condition or disease||Intervention/treatment||Phase|
|Intradialytic Hypotension||Drug: Ear pills Drug: Shengmai capsule||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||150 participants|
|Intervention Model:||Crossover Assignment|
|Official Title:||The Clinical Study of Improving the Thirst and Hypotension of Hemodialysis Patients by Ear Pills Combined With Shengmai Capsule|
|Study Start Date :||September 2013|
|Estimated Primary Completion Date :||October 2015|
|Estimated Study Completion Date :||December 2015|
No Intervention: Control group
Control group received regular hemodialysis treatment, no given Ear pills and Shengmai capsule completed in the treatment of the first stage. After 4 weeks after a washout period, two groups of cross accept the next phase of treatment.
Experimental: Ear pills and Shengmai capsule
On regular hemodialysis based on given auricular Ear pills and Shengmai capsule
Drug: Ear pills
The clinical design of this study was a randomized crossover trial. This experiment research is divided into two stages, each stage is 8 weeks. After 4 weeks after a washout period, two groups of cross accept the next phase of treatment.
Drug: Shengmai capsule
The clinical design of this study was a randomized crossover trial. This experiment research is divided into two stages, each stage is 8 weeks.
- The measurement of blood pressure [ Time Frame: 8 weeks ]According to the diagnostic criteria of hypotension in hemodialysis patients， To summarize the incidence of hypotension in the experimental group and the control group.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02583802
|Contact: Beijing University of Chinese Medicine Beijing University of Chinese Medicineemail@example.com|
|Contact: Beijing University of Chinese Medicine Beijing University of Chinese Medicine|
|Beijing University of Chinese Medicine||Recruiting|
|Beijing, Beijing, China, 100029|
|Contact: Beijing University of Chinese Medicine firstname.lastname@example.org|
|Principal Investigator:||Beijing University of Chinese Medicine Beijing University of Chinese Medicine||Chinese Ministry of Education|